United States · Markets & Finance · Quartz
Foghorn Therapeutics is cutting 40% of its workforce after Eli Lilly ends cancer drug partnership
The companies are scrapping two collaborative cancer programs and don't anticipate any further joint projects
Read the full article on Quartz Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)




